Articles published by 23andMe, Inc.
23andMe Reports First Quarter Fiscal 2025 Financial Results
August 08, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe Announces CEO’s Take-Private Proposal
August 01, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe to Report Q1 FY2025 Financial Results
July 25, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
June 28, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe Launches New Genetic Report on Bipolar Disorder
June 05, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history
May 29, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
March 20, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe Reports Third Quarter Fiscal 2024 Financial Results
February 07, 2024
From 23andMe, Inc.
Via GlobeNewswire
23andMe Announces FDA Clearance of IND Application for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
January 31, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay
January 30, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe to Report FY2024 Third Quarter Financial Results
January 24, 2024
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe Reports Second Quarter Fiscal 2024 Financial Results
November 08, 2023
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe Launches Total Health™, its Comprehensive, Prevention-Based Health Membership
November 07, 2023
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe Launches Health Action Plan to Provide Personalized Recommendations Based on Genetic and Other Health Data
October 31, 2023
From 23andMe, Inc.
Via GlobeNewswire
Tickers
ME
23andMe Announces Collaboration Extension with a New Data Licensing Agreement with GSK
October 30, 2023
From 23andMe, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.